NBPF25P

Across TCGA pan-cancer cohorts, NBPF25P RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated NBPF25P data layer compared with 4 for mutation status.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher NBPF25P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NBPF25P expression acts as an unfavorable survival marker, although some lineages such as HNSC and BRCA show a favorable association.

ACC, HNSC, and BRCA are the cancer types where NBPF25P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.254	0.643	<.001	102	view →
HNSC	OS	Tertile	All	0.836	0.688	<.001	61	view →
BRCA	OS	Tertile	All	0.978	0.941	.002	50	view →
MESO	DFS	Tertile	All	0.268	0.439	.002	49	view →
LGG	DFS	Median	All	0.663	0.813	<.001	45	view →
PAAD	OS	Median	All	0.502	0.302	.008	36	view →
CESC	DFS	Quartile	III,IV	0.100	0.852	.002	36	view →
READ	OS	Tertile	II,III,IV	0.980	0.837	.008	31	view →
ESCA	DFS	Median	IV	0.205	0.634	.006	30	view →
KIRC	DFS	Quartile	All	0.915	0.844	.007	23	view →
KICH	OS	Median	All	0.739	0.974	.003	20	view →
LIHC	OS	Tertile	II,III,IV	0.457	0.695	.002	20	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

NBPF25P–ACC (DFS)

Open the ACC breakdown →